Jazz Pharmaceuticals plc JAZZ announced that it enrolled the first patient in IMforte phase III study to evaluate its cancer drug Zepzelca (lurbinectedin) with Roche’s RHHBY Tecentriq (atezolizumab), ...
June 20 (Reuters) - Jazz Pharmaceuticals (JAZZ.O), opens new tab said on Thursday its experimental drug to treat a common movement disorder failed to reduce tremor severity in a mid-stage study, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback